Cardiovascular · PANCE / PANRE

Aortic Aneurysm (Abdominal and Thoracic)

Pathologic aortic dilation — AAA usually infrarenal and degenerative; thoracic often connective tissue or bicuspid-related; surgical thresholds drive management.

Also known as: AAA, abdominal aortic aneurysm, TAA, thoracic aortic aneurysm, aortic aneurysm

Overview

Localized dilation of the aorta to ≥1.5 times the expected normal diameter. Abdominal aortic aneurysm (AAA): infrarenal aorta ≥3.0 cm. Thoracic aortic aneurysm (TAA): ascending ≥4.5 cm or descending ≥4.0 cm in adults (varies by body surface area).

Epidemiology

AAA prevalence ~5-9% in men >65; rare in women. Strong association with smoking. TAA less common; bicuspid aortic valve and connective tissue disease drive ascending TAA in younger patients.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Aortic Aneurysm (Abdominal and Thoracic) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • AAA: smoking (most important), age >65, male sex, family history of AAA, hypertension, atherosclerosis, COPD
  • TAA ascending: bicuspid aortic valve, connective tissue disease (Marfan, Loeys-Dietz, vascular Ehlers-Danlos), Turner syndrome, family history
  • TAA descending: atherosclerosis, hypertension, prior dissection, vasculitis (Takayasu, giant cell arteritis)
  • Infections: syphilis (ascending TAA), mycotic aneurysms
  • Trauma (deceleration injury at aortic isthmus)

Pathophysiology

Loss of medial elastin and smooth muscle, with collagen disorganization, weakens the aortic wall. Wall tension increases with diameter (Laplace's law), driving further dilation and eventual rupture. Connective tissue diseases produce structurally abnormal extracellular matrix; atherosclerosis drives the degenerative AAA phenotype.

Clinical presentation

Symptoms

  • Most aneurysms are asymptomatic — detected on screening or incidentally
  • AAA expansion or impending rupture: vague abdominal or back pain, flank pain
  • Ruptured AAA: sudden severe abdominal/back pain, syncope, hypotension — surgical emergency
  • TAA: chest, back, or shoulder pain; hoarseness (recurrent laryngeal nerve), dysphagia, cough
  • Aortoenteric fistula (typically post-graft): herald GI bleed followed by exsanguination

Signs / physical exam

  • Pulsatile abdominal mass (AAA — limited sensitivity, especially in obesity)
  • Femoral bruits, diminished pulses
  • Hypotension, distended abdomen, ecchymosis (Cullen, Grey Turner) in rupture
  • TAA: usually no exam findings; signs of aortic regurgitation if root dilation
  • Connective tissue features: tall stature, arachnodactyly, hyperextensibility, ectopia lentis

Differential diagnosis

  • Aortic dissection — Acute tearing pain with pulse deficit; flap on CT angiography; treat hypertension and consider surgery
  • Renal colic — Flank pain radiating to groin with hematuria; CT shows stone, not aneurysm — but always image elderly first-time flank pain to exclude leaking AAA
  • Diverticulitis — LLQ pain with fever, CT shows colonic inflammation, not vascular abnormality
  • Mesenteric ischemia — Postprandial pain, weight loss; CT angiography of mesenteric vessels
  • Acute pancreatitis — Epigastric pain radiating to back with elevated lipase
  • MI (inferior wall) — Especially in older patients with epigastric or back pain; ECG and troponin

Diagnostic workup

Diagnostic criteria

AAA: infrarenal aortic diameter ≥3.0 cm. Surgical repair thresholds — AAA: ≥5.5 cm in men, ≥5.0 cm in women, expansion >0.5 cm in 6 months, or symptomatic. Ascending TAA: ≥5.5 cm (≥5.0 cm Marfan or bicuspid with risk factors, ≥4.5 cm Loeys-Dietz or undergoing AVR). Descending TAA: ≥5.5-6.0 cm or rapid expansion.

Labs

  • CBC, BMP, type and crossmatch (rupture)
  • Lipid panel, A1c
  • Connective tissue / inflammatory workup if clinically indicated (FBN1 gene, syphilis serology)
  • Inflammatory markers if vasculitis suspected

Imaging

  • Abdominal ultrasound — screening modality of choice for AAA (USPSTF recommends one-time screening for men 65-75 who ever smoked)
  • CT angiography — definitive sizing, anatomy, planning for endovascular repair
  • MR angiography — alternative when iodinated contrast contraindicated
  • Echocardiography for ascending TAA and aortic valve assessment
  • Chest CT with contrast for thoracic aneurysm sizing and surveillance

Diagnostic algorithm

AAA sizeSurveillanceAction
<3.0 cmNone (or single rescreen at 65-75 if ever smoker)No further imaging
3.0-3.9 cmUltrasound every 3 yearsRisk factor modification
4.0-4.9 cmUltrasound every 12 monthsRisk factor modification, smoking cessation
5.0-5.4 cmUltrasound every 6 monthsVascular surgery referral; repair women ≥5.0 cm
≥5.5 cm or rapid growth or symptomaticPre-op CTAElective repair (EVAR or open)
Surveillance and surgical thresholds for abdominal aortic aneurysm.

Treatment

First-line

  • Smoking cessation (single most effective intervention to slow AAA growth)
  • Blood pressure control — beta-blocker (metoprolol, atenolol) reduces aortic wall stress; ARB (losartan) has shown benefit in Marfan (additive to beta-blocker)
  • High-intensity statin therapy
  • Surveillance imaging by size:
  • • AAA 3.0-3.9 cm: ultrasound every 3 years
  • • AAA 4.0-4.9 cm: ultrasound every 12 months
  • • AAA 5.0-5.4 cm: ultrasound every 6 months
  • Manage cardiovascular risk factors (treat as CAD risk equivalent)

Second-line / adjunct

  • Elective AAA repair — open surgical or endovascular aneurysm repair (EVAR) at ≥5.5 cm men, ≥5.0 cm women, rapid expansion, symptomatic, or rupture
  • EVAR — lower perioperative mortality and faster recovery but higher reintervention rate; favored when anatomy permits and in higher-risk patients
  • Open repair — durable, fewer late reinterventions; preferred in younger patients with long life expectancy or unsuitable EVAR anatomy
  • Thoracic endovascular aortic repair (TEVAR) for descending TAA at threshold or complicated by rupture/penetrating ulcer
  • Open ascending aortic / root replacement — surgical repair with valve-sparing or composite graft (Bentall) for ascending TAA
  • Emergency repair for symptomatic or ruptured aneurysm regardless of size

Complications

  • Rupture and exsanguination (mortality >50% even with surgery)
  • Aortic dissection
  • Distal embolization, limb ischemia
  • Aortoenteric fistula (especially post-graft)
  • Endoleak after EVAR (types I-V; surveillance imaging required)
  • Renal/spinal cord ischemia from suprarenal or thoracoabdominal repairs

PANCE pearls

  • USPSTF recommends one-time AAA screening with abdominal ultrasound in men 65-75 who have ever smoked.
  • AAAs grow ~0.3-0.5 cm/year on average; rapid expansion (>1 cm/year) is an indication for repair regardless of absolute diameter.
  • Triad of hypotension, back pain, and pulsatile abdominal mass = ruptured AAA — to the OR, not to CT if unstable.
  • Marfan syndrome: repair ascending aorta at ≥5.0 cm (or 4.5 cm with high-risk features) — lower threshold than degenerative TAA.
  • Always check for an aortoenteric fistula in a patient with prior aortic graft and a herald GI bleed — uncontrolled exsanguination follows.

References

  • SVS 2018 AAA — The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (Chaikof et al., J Vasc Surg 2018)
  • ACC/AHA 2022 Aortic Disease — 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease (Isselbacher et al., JACC 2022)
  • USPSTF 2019 — Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement (JAMA 2019)
  • EVAR-1 — Endovascular versus Open Repair of Abdominal Aortic Aneurysm (United Kingdom EVAR Trial Investigators, NEJM 2010)

Practice Cardiovascular questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.